Published in Am J Med on March 01, 2013
Look AHEAD: Action for Health in Diabetes (LookAHEAD) | NCT00017953
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Low Albumin Levels, More Than Morbid Obesity, Are Associated With Complications After TKA. Clin Orthop Relat Res (2015) 1.39
The technology boom: a new era in obesity management. J Diabetes Sci Technol (2014) 1.15
Associations between physical activity and quality of life outcomes in adults with severe obesity: a cross-sectional study prior to the beginning of a lifestyle intervention. Health Qual Life Outcomes (2013) 0.90
Pharmacotherapy for obesity: novel agents and paradigms. Ther Adv Chronic Dis (2014) 0.87
The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus. Prog Cardiovasc Dis (2015) 0.82
Current and emerging medications for overweight or obesity in people with comorbidities. Diabetes Obes Metab (2015) 0.82
Implications of Look AHEAD for clinical trials and clinical practice. Diabetes Obes Metab (2014) 0.80
Impact of Education on Weight in Newly Diagnosed Type 2 Diabetes: Every Little Bit Helps. PLoS One (2015) 0.78
Lifestyle Intervention for People With Severe Obesity and Serious Mental Illness. Am J Prev Med (2015) 0.78
Baseline obesity status modifies effectiveness of adapted diabetes prevention program lifestyle interventions for weight management in primary care. Biomed Res Int (2013) 0.78
Failed Surgical Weight Loss Does Not Necessarily Mean Failed Metabolic Effects. Diabetes Technol Ther (2015) 0.77
The effect of intensive nutrition interventions on weight gain after kidney transplantation: protocol of a randomised controlled trial. BMC Nephrol (2014) 0.77
Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care. BMC Public Health (2014) 0.77
The preventive treatment of recurrent stone-formation: how can we improve compliance in the treatment of patients with recurrent stone disease? Urolithiasis (2015) 0.77
Pharmacological Strategies to Retard Cardiovascular Aging. Circ Res (2016) 0.76
Personalized nutrition and obesity. Ann Med (2014) 0.76
Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic. J Obes (2015) 0.75
Treatment of dyslipidemia. F1000Prime Rep (2014) 0.75
Age Differences in the Association Between Body Mass Index Class and Annualized Medicare Expenditures. J Aging Health (2015) 0.75
Running interference? Exercise and PCB-induced changes in the gut microbiome. Environ Health Perspect (2013) 0.75
Effects of a Health-Partner Intervention on Cardiovascular Risk. J Am Heart Assoc (2016) 0.75
Integrating cognitive behavioral therapy into primary care settings. Cogn Behav Pract (2014) 0.75
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77
The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) (2006) 8.25
Long-term weight loss maintenance. Am J Clin Nutr (2005) 7.42
Long-term maintenance of weight loss: current status. Health Psychol (2000) 6.03
Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA (2010) 5.77
Increases in morbid obesity in the USA: 2000-2005. Public Health (2007) 4.33
Obesity and severe obesity forecasts through 2030. Am J Prev Med (2012) 4.09
Metabolic/bariatric surgery Worldwide 2008. Obes Surg (2009) 3.66
Mortality and cardiac and vascular outcomes in extremely obese women. JAMA (2006) 3.09
Randomized clinical trials of weight loss maintenance: a review. J Cardiovasc Nurs (2008) 2.43
Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med (2010) 2.17
Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care (2011) 1.78
Reduced access to care resulting from centers of excellence initiatives in bariatric surgery. Arch Surg (2010) 1.73
The development and description of the comparison group in the Look AHEAD trial. Clin Trials (2011) 1.46
Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic. Am J Clin Nutr (2009) 1.16
Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity (Silver Spring) (2007) 1.01
Bariatric surgery or lifestyle intervention? An exploratory study of severely obese patients' motivation for two different treatments. Obes Res Clin Pract (2009) 0.88
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab (2002) 8.90
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77
Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med (2010) 8.70
The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) (2006) 8.25
Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med (2005) 8.00
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 7.09
Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA (2003) 7.07
American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc (2009) 6.07
Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA (2010) 5.77
A randomized trial comparing human e-mail counseling, computer-automated tailored counseling, and no counseling in an Internet weight loss program. Arch Intern Med (2006) 5.69
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care (2011) 5.50
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med (2008) 5.27
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24
Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol (2014) 4.30
Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med (2013) 4.25
One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring) (2009) 4.08
The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials (2002) 4.03
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Primary care physicians' attitudes about obesity and its treatment. Obes Res (2003) 3.80
Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med (2015) 3.79
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med (2010) 3.73
Physical activity and weight loss: does prescribing higher physical activity goals improve outcome? Am J Clin Nutr (2003) 3.71
The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis (2008) 3.69
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ (2011) 3.69
Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (2002) 3.68
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (2010) 3.55
A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping. Am J Hum Genet (2007) 3.39
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35
Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity (Silver Spring) (2007) 3.30
A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med (2009) 3.27
A comparison of Internet and print-based physical activity interventions. Arch Intern Med (2007) 3.18
Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol (2008) 3.16
Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes (2002) 3.14
Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) (2014) 3.10
A randomized controlled trial of a commercial internet weight loss program. Obes Res (2004) 3.06
Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care (2009) 2.95
Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med (2012) 2.90
Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med (2009) 2.89
Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab (2008) 2.87
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial. Arch Intern Med (2003) 2.83
Fast food consumption and breakfast skipping: predictors of weight gain from adolescence to adulthood in a nationally representative sample. J Adolesc Health (2006) 2.74
A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes (2007) 2.67
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation (2005) 2.63
Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA (2003) 2.60
Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med (2009) 2.59
Randomized trial of a behavioral intervention to prevent excessive gestational weight gain: the Fit for Delivery Study. Am J Clin Nutr (2011) 2.55
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol (2003) 2.51
CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med (2014) 2.50
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2013) 2.50
Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect (2006) 2.44
Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med (2006) 2.42
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes (2005) 2.42
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care (2007) 2.42